Launch of the National Strategy for Localizing Vaccine Manufacturing
VACSERA hosted the official launch ceremony of Egypt's National Strategy for Localizing Vaccine Manufacturing.
Since 1881 — More than a century of vaccine production
Protecting Egypt's Health Through Science
VACSERA, the Holding Company for Biological Products and Vaccines, is the oldest and largest manufacturer of vaccines, sera, and biological products in Egypt and Africa.
144+
Years of legacy
26+
Vaccination centers
13
Export markets
3
Subsidiary companies
Our Corporate Family
Three subsidiary companies under one mission
Holding Company
VACSERA
EgyVac
Egyptian Co. for Production of Vaccines, Sera & Drugs
Localizing life-saving biological manufacturing in Egypt.
Learn more →
EgyBlood
Egyptian Co. for Blood Transfusion Services
National blood transfusion services and derivatives.
Learn more →
EgyVet
Egyptian Co. for Veterinary Drugs & Vaccines
Animal health, autogenous vaccines, and food security.
Learn more →Specialized Research Arm
VACSERA Clinical Research Center (VCRC)
A regional hub for high-impact vaccine trials — Principal Site for Egypt's Phase III COVID-19 mega-trial.
Latest News & Announcements
View all →VCRC registered with the Supreme Council of Research Ethics
VACSERA Clinical Research Center received its CRE registration in August 2025.
Expansion of avian influenza vaccine plant in 6th of October City
GMP-compliant facility targeting 800 million doses annually for H5N1 and egg-based vaccines.
Featured Partnerships & Collaborations
World Health Organization (WHO)African Union / Africa CDCSINOVACSerum Institute of IndiaGSKSanofiGreen CrossRIVM (Netherlands)MADAUS GmbHKorvedaEl Motahida
24/7 Hotline
15292